UnitedHealth Group (NYSE:UNH) Upgraded to Buy at Argus

Argus upgraded shares of UnitedHealth Group (NYSE:UNH) from a hold rating to a buy rating in a research report released on Wednesday, MarketBeat reports. Argus currently has $400.00 price target on the healthcare conglomerate’s stock.

Other equities research analysts have also recently issued reports about the company. Evercore raised UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. Truist Financial decreased their price target on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. Jefferies Financial Group raised their price target on UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a report on Monday. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a report on Friday, January 23rd. Finally, UBS Group lowered their target price on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $377.68.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $353.51 on Wednesday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.79. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $438.85. The company has a market capitalization of $320.88 billion, a P/E ratio of 26.70, a P/E/G ratio of 1.53 and a beta of 0.40. The firm’s 50 day simple moving average is $290.76 and its two-hundred day simple moving average is $317.09.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter in the previous year, the firm earned $7.20 earnings per share. The company’s revenue for the quarter was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Research analysts expect that UnitedHealth Group will post 18.43 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s payout ratio is currently 67.02%.

Institutional Investors Weigh In On UnitedHealth Group

Large investors have recently bought and sold shares of the business. Sarver Vrooman Wealth Advisors bought a new stake in UnitedHealth Group in the fourth quarter worth $25,000. Beacon Financial Strategies CORP bought a new stake in UnitedHealth Group in the fourth quarter worth $26,000. Anfield Capital Management LLC increased its position in UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Joseph Group Capital Management bought a new position in UnitedHealth Group during the fourth quarter valued at $27,000. Finally, Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group during the fourth quarter valued at $27,000. Institutional investors own 87.86% of the company’s stock.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and raised guidance — UNH reported Q1 adjusted EPS of $7.23 (vs. consensus ~$6.76) and revenue of ~$111.7B, and raised FY‑2026 adjusted EPS guidance to above $18.25, citing improved management of medical costs. This is the main catalyst for the rally. Business Wire — Q1 Results
• Positive Sentiment: Analyst upgrades and price‑target increases — Multiple firms (Argus, RBC, Oppenheimer, Wells Fargo, Morgan Stanley, Jefferies, etc.) raised ratings or targets after the report, adding upward pressure as sell‑side momentum attracts buyers. 247wallst — Analyst Upgrades
• Positive Sentiment: AI & operational initiatives — Management flagged a meaningful AI investment (and Optum Real transaction scale), which investors view as a durable margin/efficiency tailwind if deployment scales as planned. That narrative supports higher multiple assumptions. Yahoo Finance — Q1 Deep Dive (AI)
• Positive Sentiment: Bullish options flow — Unusual activity: ~164k call options traded (≈30% above average), signaling short‑term bullish positioning from traders and institutional players.
• Neutral Sentiment: Sector sentiment spillover — UNH’s beat dragged peers higher (CVS, Humana, Centene); positive industry momentum can amplify the stock move but doesn’t change UNH’s fundamentals. Yahoo — Sector Impact
• Negative Sentiment: Ongoing risks remain — Management warned of challenges around a Medicare obesity‑drug pilot and cautioned that medical‑cost dynamics are still the key risk; if costs reaccelerate, margins and guidance could reverse. Reuters — Medicare Obesity Drug Pilot Challenges

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.